Karo Pharma AB (publ)
Karo Pharma AB (publ) (KARBF) Revenue
Annual & quarterly revenue history · segment & region breakdown
KARBF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsKaro Pharma AB (publ) trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare KARBF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Karo Pharma AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Karo Pharma AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Karo Pharma AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KARBF revenue · 4 questionsKARBF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Karo Pharma AB (publ) SEC filings · GAAP · Karo Pharma AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026